CD19 CAR T Arm
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University Hospital, Montpellier
Overview
CD19 CAR T Arm is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
CD19 CAR T Arm clinical trials
Explore related
Medical disclaimer. This page summarizes research about CD19 CAR T Arm for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.